Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CLNN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 9.671M
March 31, 2026 5.939M
December 31, 2025 5.189M
September 30, 2025 7.925M
June 30, 2025 7.285M
March 31, 2025 9.832M
December 31, 2024 12.16M
September 30, 2024 14.64M
June 30, 2024 21.68M
March 31, 2024 27.91M
December 31, 2023 35.00M
September 30, 2023 42.11M
June 30, 2023 49.24M
March 31, 2023 18.44M
December 31, 2022 23.32M
September 30, 2022 16.23M
June 30, 2022 26.29M
Date Value
March 31, 2022 36.52M
December 31, 2021 50.29M
September 30, 2021 60.55M
June 30, 2021 63.01M
March 31, 2021 48.04M
December 31, 2020 59.28M
September 30, 2020 0.4401M
June 30, 2020
March 31, 2020
December 31, 2019 0.4294M
September 30, 2019 0.4482M
June 30, 2019 0.5366M
March 31, 2019 0.6485M
December 31, 2018 0.7438M
September 30, 2018 0.756M
June 30, 2018 0.0444M
March 31, 2018 0.0628M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
NovelStem International Corp. 0.0562M
Brainstorm Cell Therapeutics, Inc. 0.022M
Summit Therapeutics, Inc. 691.00M
Kezar Life Sciences, Inc. 66.23M
Protara Therapeutics, Inc. 142.49M